Posted by Michael Wonder on 18 Mar 2025
Zorvye cream 0.15% approved by Health Canada for the treatment of mild to moderate atopic dermatitis in adults and children as young as six years of age
17 March 2025 - Once daily, steroid free topical treatment designed to rapidly reduce itch and proactively support long term disease control.
Arcutis Canada announced today that Health Canada has approved Zorvye (roflumilast cream 0.15%), for the treatment of mild to moderate atopic dermatitis in adults and children ages 6 years and older.
